Tirzepatide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes
and [5] stability under different food/feed processing conditions [260]
Modifier -51 may apply when 12001 is billed alongside non-repair procedures in the same session, though Medicare applies multiple-procedure reductions automatically
Clinical Evidence: Semaglutide and Sleep Apnea Outcomes A 2023 cardiovascular outcomes trial found that patients using semaglutide experienced a 39% relative risk reduction in obstructive sleep apnea severity compared to placebo, driven primarily by weight loss
Contraindications include personal or family history of thyroid cancer, multiple endocrine neoplasia type 2, severe pancreatitis, or active gastroparesis
Planning on losing a few more